Suppr超能文献

Identification and SAR exploration of a novel series of Legumain inhibitors.

作者信息

Eddie Sharon L, Gregson Aaron, Graham Emma, Burton Stephanie, Harrison Timothy, Burden Roberta, Scott Christopher J, Mullan Paul B, Williams Rich

机构信息

CCRCB Drug Discovery Group, Centre for Cancer Research and Cell Biology, Queen's University Belfast, 97 Lisburn Rd., Belfast BT9 7BL, United Kingdom.

Almac Discovery, Health Sciences Building, Queen's University Belfast, 97 Lisburn Rd., Belfast BT9 7AE, United Kingdom.

出版信息

Bioorg Med Chem Lett. 2019 Jun 15;29(12):1546-1548. doi: 10.1016/j.bmcl.2019.03.019. Epub 2019 Mar 29.

Abstract

This letter describes the development of a series of potent and selective small molecule Legumain inhibitors suitable as chemical probes for in vitro experiments. Our previous research had identified a dipeptide inhibitor utilizing a semi-reversible cyano warhead that generated 2, a cell active inhibitor. This work explores an alternative P2-P3 linker and further SAR exploration of the P3 group which led to the identification of 16i, a highly potent inhibitor with excellent physiochemical properties.

摘要

相似文献

1
Identification and SAR exploration of a novel series of Legumain inhibitors.
Bioorg Med Chem Lett. 2019 Jun 15;29(12):1546-1548. doi: 10.1016/j.bmcl.2019.03.019. Epub 2019 Mar 29.
2
Development of a potent and selective cell penetrant Legumain inhibitor.
Bioorg Med Chem Lett. 2015 Dec 1;25(23):5642-5. doi: 10.1016/j.bmcl.2015.10.001. Epub 2015 Oct 9.
3
P3 SAR exploration of biphenyl carbamate based Legumain inhibitors.
Bioorg Med Chem Lett. 2014 Jun 1;24(11):2521-4. doi: 10.1016/j.bmcl.2014.04.002. Epub 2014 Apr 12.
4
Flat SAR of P3-methylsulphonamide based small molecule legumain inhibitors.
Bioorg Med Chem Lett. 2016 Jan 15;26(2):413-416. doi: 10.1016/j.bmcl.2015.11.101. Epub 2015 Nov 28.
5
Identification of potent and reversible cruzipain inhibitors for the treatment of Chagas disease.
Bioorg Med Chem Lett. 2010 Dec 15;20(24):7444-9. doi: 10.1016/j.bmcl.2010.10.015. Epub 2010 Oct 12.
6
Development of novel dipeptide-like rhodesain inhibitors containing the 3-bromoisoxazoline warhead in a constrained conformation.
Bioorg Med Chem. 2015 Nov 1;23(21):7053-60. doi: 10.1016/j.bmc.2015.09.029. Epub 2015 Sep 21.
7
A comparative study of warheads for design of cysteine protease inhibitors.
Bioorg Med Chem Lett. 2017 Nov 15;27(22):5031-5035. doi: 10.1016/j.bmcl.2017.10.002. Epub 2017 Oct 3.
8
Peptidomimetics containing a vinyl ketone warhead as falcipain-2 inhibitors.
Eur J Med Chem. 2011 Jun;46(6):2058-65. doi: 10.1016/j.ejmech.2011.02.058. Epub 2011 Mar 3.
9
Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease.
Bioorg Med Chem. 2005 Mar 15;13(6):2141-56. doi: 10.1016/j.bmc.2004.12.053.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验